Centro Hospitalar Universitário de Lisboa Central (CHULC), 1069-166, Lisbon, Portugal.
Interventional Radiology Unit, Hospital Curry Cabral, Centro Hospitalar Universitário de Lisboa Central (CHULC), 1069-166, Lisbon, Portugal.
Cardiovasc Intervent Radiol. 2020 Oct;43(10):1449-1459. doi: 10.1007/s00270-020-02604-4. Epub 2020 Aug 2.
Analyze the impact of endovascular revascularization on major amputation rates and wound healing for patients with diabetic foot ulcers (DFUs).
Single-center retrospective study from 2014-2018 including 314 patients with DFUs submitted to endovascular revascularizations. Group A-patients with a successful endovascular revascularization (n = 285; 90.8%); Group B-patients submitted to a failed attempt of endovascular revascularization (n = 29; 9.2%). Baseline data were not significantly different between the 2 groups (p > 0.05). Both groups were compared regarding: major amputation rates; wound healing, mortality and adverse events. Survival and regression analyses were used.
Mean follow-up time was 734.1 ± 610.2 days. Major amputation rates were 3.9% versus 24.1% (p < 0.0001) and complete wound healing was 53.7% versus 20.7% (p < 0.0001) for patients from Group A versus Group B, respectively. Major adverse events were registered in 2 patients (one from each group); minor adverse events included 10 patients from Group A and 2 patients from Group B (p = 0.3654). Major amputation rates were: 3.9% versus 27.5% at 1 year; 4.6% versus 27.5% at 2-5 years for Group A versus Group B, respectively (p < 0.0001). Survival rates were: 87.8% at 1 year; 84.4% at 2 years; and 77.9% at 5 years with no significant differences between groups. Predictors for major amputation included failed revascularization (p < 0.0001), older age (p = 0.0394), prior stroke (0.0018), dialysis (0.0476). Predictors for mortality included older age (p < 0.0001) and coronary artery disease (p = 0.0388).
Endovascular revascularization for patients with DFUs is safe and has a significant impact on limb salvage and wound healing.
分析血管腔内血管重建术对糖尿病足溃疡(DFU)患者的主要截肢率和伤口愈合的影响。
这是一项 2014 年至 2018 年来自单一中心的回顾性研究,共纳入 314 例接受血管腔内血管重建术的 DFU 患者。A 组为血管腔内血管重建成功的患者(n=285;90.8%);B 组为血管腔内血管重建失败的患者(n=29;9.2%)。两组患者的基线资料无统计学差异(p>0.05)。比较两组患者的主要截肢率、伤口愈合、死亡率和不良事件。采用生存和回归分析。
平均随访时间为 734.1±610.2 天。A 组的主要截肢率为 3.9%,B 组为 24.1%(p<0.0001);A 组完全愈合率为 53.7%,B 组为 20.7%(p<0.0001)。A 组有 2 例(每组 1 例)发生主要不良事件,B 组有 10 例(p=0.3654)发生轻微不良事件。A 组 1 年时的主要截肢率为 3.9%,2-5 年时为 4.6%;B 组 1 年时为 27.5%,2-5 年时为 27.5%(p<0.0001)。A 组 1 年的生存率为 87.8%,2 年为 84.4%,5 年为 77.9%,两组间无显著差异。主要截肢的预测因素包括血管重建失败(p<0.0001)、年龄较大(p=0.0394)、既往中风(0.0018)、透析(0.0476)。死亡的预测因素包括年龄较大(p<0.0001)和冠心病(p=0.0388)。
DFU 患者的血管腔内血管重建术安全有效,对肢体挽救和伤口愈合有显著影响。